Splenectomy for Primary Sjögren’s Syndrome Associated with Massive Splenomegaly: Two Case Reports

Fang Gui,* Li-Xuan Zhou,* Xue-Mei Liu, Yong-Long He, Qi-Bin Yang Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qi-Bin Yang, Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, 1 Maoyuannan Road, Nanchong, Sichuan, 637000, People’s Republic of China, Tel +86-817-259-8221, Email [email protected]: Primary Sjögren’s syndrome (pSS) is an autoimmune disease characterized by exocrine glands involving mainly the lacrimal and salivary glands. Splenomegaly from pSS is a rare clinical feature unless the pSS is complicated by lymphoma. Splenectomy could exclude malignant lymphoma, reduce the risk of spontaneous spleen rupture and remove hypersplenism to improve pancytopenia.Case Presentation: We reported the case of a 49-year-old female patient who was diagnosed with pSS according to dry mouth, dry eyes, splenomegaly, multiple positive autoantibodies, positive Schirmer’s test and biopsy of labial gland with decreased number of acini and focal lymphocytic infiltration. Due to hematological involvement and liver dysfunction repeatedly, the pSS patient was admitted to the hospital and treated with glucocorticoids, immunosuppressants and hepatoprotective drugs. However, the pancytopenia failed to improve. Considering pancytopenia of the pSS patient caused by massive splenomegaly, splenectomy was recommended to the patient. The hematological involvement was significantly improved after splenectomy. Besides, another 46-year-old woman with a similar clinical manifestation was diagnosed with pSS complicated by massive splenomegaly, however, the patient refused to undergo the splenectomy.Conclusion: Splenectomy may be an effective treatment of pSS complicated by massive splenomegaly resulting in hematological involvement.Keywords: Sjogren’s syndrome, splenomegaly, splenectomy, autoimmune diseases, case report

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2025-08-04
Primary Topic
Thermal Analysis in Power Transmission
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Splenectomy for Primary Sjögren’s Syndrome Associated with Massive Splenomegaly: Two Case Reports

Dove Medical Press (Taylor and Francis Group)
Thermal Analysis in Power Transmission
article

Splenectomy for Primary Sjögren’s Syndrome Associated with Massive Splenomegaly: Two Case Reports

article en

Abstract

Fang Gui,* Li-Xuan Zhou,* Xue-Mei Liu, Yong-Long He, Qi-Bin Yang Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Qi-Bin Yang, Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, 1 Maoyuannan Road, Nanchong, Sichuan, 637000, People’s Republic of China, Tel +86-817-259-8221, Email [email protected]: Primary Sjögren’s syndrome (pSS) is an autoimmune disease characterized by exocrine glands involving mainly the lacrimal and salivary glands. Splenomegaly from pSS is a rare clinical feature unless the pSS is complicated by lymphoma. Splenectomy could exclude malignant lymphoma, reduce the risk of spontaneous spleen rupture and remove hypersplenism to improve pancytopenia.Case Presentation: We reported the case of a 49-year-old female patient who was diagnosed with pSS according to dry mouth, dry eyes, splenomegaly, multiple positive autoantibodies, positive Schirmer’s test and biopsy of labial gland with decreased number of acini and focal lymphocytic infiltration. Due to hematological involvement and liver dysfunction repeatedly, the pSS patient was admitted to the hospital and treated with glucocorticoids, immunosuppressants and hepatoprotective drugs. However, the pancytopenia failed to improve. Considering pancytopenia of the pSS patient caused by massive splenomegaly, splenectomy was recommended to the patient. The hematological involvement was significantly improved after splenectomy. Besides, another 46-year-old woman with a similar clinical manifestation was diagnosed with pSS complicated by massive splenomegaly, however, the patient refused to undergo the splenectomy.Conclusion: Splenectomy may be an effective treatment of pSS complicated by massive splenomegaly resulting in hematological involvement.Keywords: Sjogren’s syndrome, splenomegaly, splenectomy, autoimmune diseases, case report

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 44%
Thermal Analysis in Power Transmission
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Splenectomy for Primary Sjögren’s Syndrome Associated with Massive Splenomegaly: Two Case Reports · Dove Medical Press (Taylor and Francis Group) (2025) | TGRS Research Map | TGRS